Pharmaceutical Technology

MAY 24, 2023

Forge Biologics has joined the public-private collaboration, the Bespoke Gene Therapy Consortium (BGTC), to expedite the development and manufacture of new AAV [adeno-associated virus] gene therapies to treat patients with rare diseases. Shilling was appointed to represent the company on the steering committee of the BGTC.

Gene Therapy 242

Gene Therapy Gene Development Manufacturing 242

Pharmaceutical Technology

JUNE 9, 2023

Co-led by Venrock Healthcare Capital Partners (Venrock) and Enavate Sciences, the financing round has seen participation from new investors Wellington Management and Bain Capital Life Sciences. It is also preparing for a swift transition to Phase III development.

Clinical Development 147

Clinical Development Development Life Science Clinical Trials 147

Pharmaceutical Technology

JANUARY 5, 2025

Fosigotifator is under clinical development by Calico Life Sciences and currently in Phase II for Unspecified Central Nervous System Disorders.

Life Science 100

Life Science Clinical Development Development 100

XTalks

OCTOBER 24, 2024

Panagos, an industry veteran with extensive experience in the healthcare and life sciences sector, takes over from Colin Shannon, who served as CEO for one year following the company’s acquisition by a consortium of private equity firms. Shannon has now been appointed Executive Chairman of Syneos.

Life Science 105

Life Science Clinical Development Development Clinical Research 105

XTalks

FEBRUARY 5, 2025

In this episode, Ayesha spoke with Mario Marcondes, MD, PhD, VP Head of Clinical Development at Nektar Therapeutics , a company focused on the discovery and development of novel therapies for autoimmune disorders and cancer. Subscribe to the Xtalks Life Science Podcast to never miss a new episode.

Clinical Development 59

Clinical Development Development Life Science Clinical Trials 59

XTalks

JUNE 4, 2024

In the ever-evolving landscape of pharmaceutical development, the complexity of early phase clinical trials is increasing. This surge in complexity is driven by escalating drug development costs, heightened competition and advanced scientific innovations. And that has a lot of downstream consequences.” This trend, which Dr.

Clinical Development 110

Clinical Development Development Clinical Trials Clinical Trials 110

XTalks

MAY 28, 2024

Our discussion delved into the potential of DHTs to reshape how clinical trials are conducted, making them not only faster and less costly but also more patient-centric and reflective of real-world outcomes. This approach can speed up development and improve data quality, potentially leading to more effective and personalized therapies.

Clinical Development 116

Clinical Development Development Clinical Trials Clinical Trials 116

pharmaphorum

MARCH 8, 2022

How did you get into life sciences? After a few years, I decided I wanted to move into the commercial side of the business, so I completed an MBA and went on to hold various positions in Corporate Business Development, Life Science and Healthcare. What has your career path been?

Life Science 98

Life Science Engineer Scientist Doctors 98

XTalks

APRIL 14, 2021

FDA-mandated clinical holds, strategic partnership breakups and $800 million biotech acquisitions. She shares how well the firms have weathered the COVID-19 pandemic, and the team discusses the outlook for the drug development industry in general. Subscribe to the Xtalks Life Science Podcast to never miss a new episode.

Life Science 75

Life Science Gene Therapy Development Drugs 75

Pharmaceutical Technology

JUNE 6, 2023

Led by Bain Capital Life Sciences, the financing round has also seen participation from Sofinnova Investments, TCGX and Wellington Management. Gildeuretinol is the first and only medicine in clinical development to treat Stargardt disease by reducing vitamin A dimerization in the eye, without affecting normal vision.

Genetics 279

Genetics Life Science Trials Clinical Development 279

Outsourcing Pharma

APRIL 16, 2024

Bios Health Group, a leading strategic and investment partner for life science companies and investors, has officially introduced the Bios Innovation Circle.

Life Science 81

Life Science Clinical Development Development 81

Pharmaceutical Technology

AUGUST 9, 2022

In the clinical development programme, 1,944 epilepsy patients received cenobamate treatment. Discovered by SK Biopharmaceuticals and SK life science, cenobamate is a new small molecule anti-seizure therapy.

Life Science 246

Life Science Clinical Development Trials Marketing 246

ACRP blog

OCTOBER 10, 2024

The same is true in life sciences. As the technology develops, however, it will offer more opportunities to expedite drug discovery processes, streamline clinical trials, and speed up regulatory approvals. MGI puts the value of this contribution to clinical development at $15 billion to $25 b illion.

Clinical Trials 69

Clinical Trials Clinical Trials Trials Life Science 69

Outsourcing Pharma

AUGUST 22, 2023

Those in the life sciences industry needing some creative input can now turn to Bios Health Group who have recently launched into the space.

Life Science 81

Life Science Clinical Development Development 81

XTalks

JANUARY 5, 2021

The pandemic itself will also continue to spur innovations and changes such as greater shifts towards decentralized clinical trials and patient-centric approaches. In addition to vaccines, there are handfuls of drugs currently being evaluated in clinical trials for the treatment of COVID-19. 1. COVID-19 Pandemic: An Evolving Era.

Life Science 98

Life Science Clinical Trials Clinical Trials Trials 98

BioTech 365

SEPTEMBER 29, 2021

Avacta Group plc: Achievement of Pre-clinical Development Milestone in LG Chem Life Sciences Partnership Avacta Group plc: Achievement of Pre-clinical Development Milestone in LG Chem Life Sciences Partnership CAMBRIDGE & WETHERBY, England–(BUSINESS WIRE)–Avacta Group plc (AIM: AVCT), a clinical stage … Continue reading → (..)

Life Science 40

Life Science Clinical Development Development 40

XTalks

JANUARY 7, 2025

billion Announced : February 2019 Closed : March 2020 In 2019, Danaher, a life sciences and diagnostics innovator, acquired the Biopharma business from General Electric Companys (GE) Life Sciences division. Now operating as Cytiva, the business functions as a standalone company within Danahers Life Sciences segment.

Life Science 105

Life Science Manufacturing Production Clinical Development 105

XTalks

NOVEMBER 26, 2024

BridgeBio’s leadership, including Neil Kumar, emphasizes the significance of Attruby’s approval as a cornerstone in their mission to develop therapies for genetic diseases. Looking ahead, the company plans to pursue regulatory approvals in Japan and Brazil, further expanding access to this life-changing treatment.

Genetic Disease 105

Genetic Disease Genetics Protein Clinical Development 105

XTalks

OCTOBER 23, 2024

Hanger encourages new clinical trial professionals to embrace innovation and stay patient-focused. She hopes her work at CTTI will influence the development of a clinical trial system that is more efficient, inclusive and better aligned with patient needs. Tune in to learn how CTTI is leading efforts to reshape clinical trials.

Clinical Research 64

Clinical Research Clinical Trials Clinical Trials Life Science 64

pharmaphorum

JANUARY 5, 2024

Beckley Psytech has announced that is has received substantial strategic investment from atai Life Sciences, totalling $50 million, to accelerate the clinical development of short-duration psychedelics.

Life Science 97

Life Science Clinical Development Development 97

pharmaphorum

APRIL 19, 2021

The UK’s unique offering as a life sciences research hub helped convince US biotech Novavax to develop its COVID-19 jab there, according to the head of the country’s Vaccines Taskforce. . If you look at the development, we signed 15,000 people in six weeks in a trial set up by the NHS.

Vaccine 141

Vaccine Vaccination Manufacturing Clinical Development 141

pharmaphorum

NOVEMBER 12, 2020

Swiss startup Synendos Therapeutics has raised CHF 20 million (almost $22 million) in first-round financing that will be used to develop its endocannabinoid drugs for central nervous system disorders. Synendos says the cash will allow it to take its lead product SYT-510 through preclinical and proof-of-concept clinical development.

Development 106

Development Drugs Life Science Clinical Development 106

pharmaphorum

MARCH 17, 2021

Charity-funded medical research is a vital cog in the clinical development machine – but COVID-19 has left it facing an existential threat. It means groups have had to take difficult decisions around research funding – decisions that could have long-term reverberations for the whole clinical development sector. “We

Research 98

Research Development Life Science Clinical Development 98

Pharmaceutical Technology

APRIL 12, 2023

Cognizant and Boehringer Ingelheim are collaborating on an integrated cloud platform to enhance the speed and quality of medicinal therapy development. Cognizant will leverage the Veeva Development Cloud platform to help Boehringer Ingelheim to merge medicinal development processes and data into a connected technology ecosystem.

Medicine 130

Medicine Life Science Development Branding 130

XTalks

NOVEMBER 13, 2024

In this episode, Ayesha spoke with Shaheen Lakhan, MD, PhD, Chief Medical and Scientific Officer, Click Therapeutics , a company focused on developing software as prescription medical treatments for people with unmet medical needs. Subscribe to the Xtalks Life Science Podcast to never miss a new episode.

Life Science 59

Life Science Medicine Drug Delivery Clinical Development 59

XTalks

NOVEMBER 21, 2024

Jeff Emmick, MD, PhD, senior vice president, product development, Lilly said, “These results underscore the critical role of long-term therapy with effective treatments like tirzepatide to achieve and maintain weight reduction.”

Sales 105

Sales Insulin Drugs Trials 105

XTalks

OCTOBER 7, 2020

However, these complex treatments present challenges to developers over and above the well-documented hurdles of rare-disease research. The Xtalks White Paper, The Intersection of Rare Disease and Advanced Therapies: What it Means for Clinical Development , is available for free download. Adjusting for COVID-19.

Development 98

Development Gene Therapy Clinical Trials Clinical Trials 98

Cloudbyz

SEPTEMBER 11, 2024

This prestigious recognition positions Cloudbyz among the top performers in delivering intuitive and scalable EDC solutions to life sciences organizations worldwide. This prestigious recognition positions Cloudbyz among the top performers in delivering intuitive and scalable EDC solutions to life sciences organizations worldwide.

Life Science 52

Life Science Clinical Trials Clinical Trials Compliance 52

pharmaphorum

SEPTEMBER 3, 2020

UK biotech Compass Pathways is planning a $100 million US IPO as it seeks to further develop its depression treatment based on psilocybin – an active ingredient that can be found in magic mushrooms.

Drugs 116

Drugs Life Science Clinical Development Regulation 116

Outsourcing Pharma

MARCH 9, 2021

The development technology firm plans to use the funds, sourced from a wide range of investors, to expand its dev-ops platform and expand its global reach.

Life Science 73

Life Science Development Clinical Development 73

XTalks

NOVEMBER 15, 2023

This episode features an interview with Dr. Lahar Mehta, Head of Global Clinical Development at Amylyx Pharmaceuticals, who spoke to Xtalks about Amylyx’s clinical trial design of ORION, a Phase III Global Study of AMX0035 (Relyvrio) in Progressive Supranuclear Palsy (PSP).

Life Science 52

Life Science Trials Clinical Trials Clinical Trials 52

BioTech 365

MAY 12, 2021

Kezar Life Sciences Reports First Quarter Financial Results and Provides Business Updates Kezar Life Sciences Reports First Quarter Financial Results and Provides Business Updates KZR-616 clinical development in three severe autoimmune diseases is advancing with several data readouts expected in … Continue reading →

Life Science 40

Life Science Clinical Development Development 40

XTalks

MARCH 1, 2021

The study is part of a broad development plan to assess the durability of the immunogenic responses elicited by its vaccine and the emergence of new SARS-CoV-2 variants. Our proactive clinical development strategy aims to create the foundation today, that will enable us to address the challenges of tomorrow.

Vaccine 111

Vaccine Vaccination Development In-Vitro 111

pharmaphorum

SEPTEMBER 3, 2020

The area is being reimagined as a life sciences and technology hub and is already home to the Francis Crick Institute biomedical research organisation. With AI the pharma industry hopes to reduce the number of drugs that fail during the clinical development process, a huge financial drain on the industry.

Life Science 114

Life Science Scientist Engineer Pharma Companies 114

XTalks

OCTOBER 4, 2023

How do you make strategic decisions around products that are in the early stage of development and are still years from regulatory approval and launch? In the specialized, personalized and advanced medicines spaces, this work should start very early — as early as Phase I or Phase II of clinical development.

Marketing 105

Marketing Development Drugs Gene Therapy 105

BioTech 365

MARCH 11, 2021

Kezar Life Sciences Reports Fourth Quarter and Year End 2020 Financial Results and Provides Business Updates Kezar Life Sciences Reports Fourth Quarter and Year End 2020 Financial Results and Provides Business Updates KZR-616 clinical development in three severe autoimmune diseases … Continue reading →

Life Science 40

Life Science Clinical Development Development 40

pharmaphorum

MAY 27, 2021

Sheila Rocchio highlights four key areas life sciences must improve on as an industry to drive real change in how clinical trials are conducted. This is definitely a time for the life sciences industry to be proud of our accomplishments. We need to be prepared to do it again. Increase in data sources and providers.

Clinical Trials 119

Clinical Trials Clinical Trials Trials Life Science 119